Form D · Biotechnology
Cross Vascular, Inc.
Solana Beach, CA · CIK 0001826652
Offering snapshot reported Apr 29, 2021 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 16, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2021 | Initial | $3,500,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-397651
Source: Form D, filed Apr 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brad Klos | Director, Executive |
| Randell Werneth | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
535 Stevens Ave. West
Solana Beach, CA, 92075
Solana Beach, CA, 92075